ea0099ep281 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024
Vrachnis Dionysios
, Efstathiadou Zoi
, Goulis Dimitrios
, Kassi Eva
, Lymniati Christina
, Ntali Georgia
, Peppa Melpomeni
, Stavrinos Konstantinos
, Vryonidou Andromahi
, Xekouki Paraskevi
, Stratakis Constantine
Fluasterone (16-α-fluoro-5-androsten-17-one) is a structural analogue of dehydroepiandrosterone (DHEA) that retains DHEA clinical properties without its androgenic effects. In animal models, fluasterone exhibits DHEA-like effects, including anti-inflammatory, anti-proliferative, and anti-diabetic properties but is consistently more potent than DHEA. An orphan-drug designation for fluasterone has been granted by the FDA for treatment of Cushings syndrome (CS), includ...